Literature DB >> 1420273

Distinct metal ion binding sites on Ca(2+)-activated K+ channels in inside-out patches of human erythrocytes.

T Leinders1, R G van Kleef, H P Vijverberg.   

Abstract

Effects of Cd2+, Co2+, Pb2+, Fe2+ and Mg2+ (1-100 microM) on single-channel properties of the intermediate conductance Ca(2+)-activated K+ (CaK) channels were investigated in inside-out patches of human erythrocytes in a physiological K+ gradient. Cd2+, Co2+ and Pb2+, but not Fe2+ and Mg2+, were able to induce CaK channel openings. The potency of the metals to open CaK channels in human erythrocytes follows the sequence Pb2+, Cd2+ > Ca2+ > or = Co2+ >> Mg2+, Fe2+. At higher concentrations Pb2+, Cd2+ and Co2+ block the CaK channel by reducing the opening frequency and the single-channel current amplitude. The potency of the metals to reduce CaK channel opening frequency follows the sequence Pb2+ > Cd2+, Co2+ >> Ca2+, which differs from the potency sequence Cd2+ > Pb2+, Co2+ >> Ca2+ to reduce the unitary single-channel current amplitude. Fe2+ reduced the channel opening frequency and enhanced the two open times of CaK channels activated by Ca2+, whereas up to 100 microM Mg2+ had no effect on any of the measured single-channel parameters. It is concluded that the activation of CaK channels of human erythrocytes by various metal ions occurs through an interaction with the same regulatory site at which Ca2+ activates these channels. The different potency orders for the activating and blocking effects suggest the presence of at least one activation and two blocking sites. A modulatory binding site for Fe2+ exists as well. In addition, the CaK channels in human erythrocytes are distinct from other subtypes of Ca(2+)-activated K+ channels in their sensitivity to the metal ions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1420273     DOI: 10.1016/0005-2736(92)90256-l

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Differences in the actions of some blockers of the calcium-activated potassium permeability in mammalian red cells.

Authors:  D C Benton; C J Roxburgh; C R Ganellin; M A Shiner; D H Jenkinson
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

2.  Mg²⁺ modulation of the single-channel properties of KCa3.1 in human erythroleukemia cells.

Authors:  Colin J Stoneking; Michael J Mason
Journal:  Pflugers Arch       Date:  2013-11-06       Impact factor: 3.657

3.  Compounds that block both intermediate-conductance (IK(Ca)) and small-conductance (SK(Ca)) calcium-activated potassium channels.

Authors:  M Malik-Hall; C R Ganellin; D Galanakis; D H Jenkinson
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

4.  Dose dependent reduction of erythroid progenitor cells and inappropriate erythropoietin response in exposure to lead: new aspects of anaemia induced by lead.

Authors:  W Osterode; U Barnas; K Geissler
Journal:  Occup Environ Med       Date:  1999-02       Impact factor: 4.402

5.  Arsenic and manganese alter lead deposition in the rat.

Authors:  V Andrade; M L Mateus; D Santos; M Aschner; M C Batoreu; A P Marreilha dos Santos
Journal:  Biol Trace Elem Res       Date:  2014-04-09       Impact factor: 3.738

6.  A novel type of ATP block on a Ca(2+)-activated K(+) channel from bullfrog erythrocytes.

Authors:  M Shindo; Y Imai; Y Sohma
Journal:  Biophys J       Date:  2000-07       Impact factor: 4.033

7.  Differential effects of heavy metal ions on Ca(2+)-dependent K+ channels.

Authors:  H P Vijverberg; T Leinders-Zufall; R G van Kleef
Journal:  Cell Mol Neurobiol       Date:  1994-12       Impact factor: 5.046

Review 8.  Metal ion-induced permeability changes in cell membranes: a minireview.

Authors:  T Kiss; O Osipenko
Journal:  Cell Mol Neurobiol       Date:  1994-12       Impact factor: 5.046

9.  Iron accumulation in bronchial epithelial cells is dependent on concurrent sodium transport.

Authors:  Jennifer L Turi; Claude A Piantadosi; Jackie D Stonehuerner; Andrew J Ghio
Journal:  Biometals       Date:  2008-05-16       Impact factor: 2.949

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.